98%
921
2 minutes
20
Objective: To investigate the visual and anatomical outcomes of Boston keratoprosthesis (Kpro) type 1 reimplantation.
Design: Subgroup analysis of multicentre prospective cohort study.
Participants: Of 303 eyes that underwent Kpro implantation between January 2003 and July 2008 by 1 of 19 surgeons at 18 medical centres, 13 eyes of 13 patients who underwent reimplantation of Boston Kpro type 1 were compared with 13 eyes of 13 diagnosis-matched patients who underwent initial implantation.
Methods: Forms reporting preoperative, intraoperative, and postoperative parameters were prospectively collected and analyzed. Main outcome measures were Kpro retention and logMAR visual acuity.
Results: After a mean follow-up time of 17.1 ± 17.6 months, the retention of both initial and repeat Kpro implantation was 92.3% (12/13 in both groups), and 62% of initial implantation and 58% of repeat implantation eyes achieved visual acuity better than 20/200. Vision worse than 20/200 was often due to glaucoma or posterior segment pathology. Best-recorded logMAR visual acuity was significantly improved postoperatively in both groups (p < 0.001), and there was no statistically significant difference in final logMAR visual acuity between the 2 groups (p = 0.89). Sterile keratolysis (n = 4) and fungal infection (n = 5) were the most common causes of initial Kpro failure in the repeat Kpro group. The single failure in the repeat Kpro implantation group was due to fungal keratitis, and in the control group it was related to Kpro extrusion.
Conclusions: Repeat Kpro implantation is a viable option after failed initial Kpro, with visual and anatomical outcomes comparable to those of initial procedures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561078 | PMC |
http://dx.doi.org/10.1016/j.jcjo.2017.10.021 | DOI Listing |
Am J Ophthalmol
September 2025
Department of Ophthalmology, Université de Montréal, Montréal, Québec, Canada.
Purpose: To evaluate the incidence, risk factors, management strategies, and visual outcomes of retinal detachment (RD) following Boston Keratoprosthesis Type 1 (KPro) implantation.
Design: Single-center, retrospective observational case series.
Methods: Medical records of 157 eyes from 122 adult patients who underwent Boston Type 1 KPro implantation at a tertiary care center between 2008 and 2022 were reviewed.
Cornea
August 2025
Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico; and.
Purpose: To describe the surgical technique for implantation of a novel flexible, suturable, intrastromal synthetic cornea device.
Methods: This report is a description of a novel surgical technique. Adult patients (≥18 years) with corneal edema who met specific inclusion criteria were enrolled.
Can J Ophthalmol
August 2025
Department of Ophthalmology, Université de Montréal, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Objective: The Boston Type I keratoprosthesis (B-KPro) is a synthetic corneal implant used to restore vision in cases of corneal blindness. While the B-KPro can achieve a visual acuity of better than 20/200, it is associated with a risk of implant failure. In cases of failure, a repeat B-KPro may offer another opportunity for vision restoration.
View Article and Find Full Text PDFAm J Ophthalmol Case Rep
September 2025
Instituto de Oftalmología Fundación Conde de Valenciana IAP, Mexico City, Mexico.
Purpose: To describe the use of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) combined with amniotic membrane graft (AMG) as a novel surgical technique for infectious keratitis in a patient with Boston Keratoprosthesis (B-Kpro) type 1 Lucia.
Methods: A 91-year-old woman with a history of B-Kpro type 1 Lucia implantation in both eyes presented for routine follow-up complaining of pain and redness in the left eye. Slit-lamp examination revealed a 6 mm corneal infiltrate with an epithelial defect adjacent to the optic stem.
Int Ophthalmol Clin
July 2025
Department of Ophthalmology, Massachusetts Eye and Ear, Boston, MA.
Decades of research and innovation have led to the development of modern keratoprostheses (KPros) designed to replace the function of the native human cornea. The Boston Keratoprosthesis (B-KPro) Type I remains the most widely used KPro worldwide. Ongoing refinements and modified versions of the B-KPro, as well as novel, fully synthetic devices, aim to enhance durability and biocompatibility, reduce complications, and expand accessibility to KPros across the globe.
View Article and Find Full Text PDF